Literature DB >> 19561064

Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Shannon M Lynch1, Alina Vrieling, Jay H Lubin, Peter Kraft, Julie B Mendelsohn, Patricia Hartge, Federico Canzian, Emily Steplowski, Alan A Arslan, Myron Gross, Kathy Helzlsouer, Eric J Jacobs, Andrea LaCroix, Gloria Petersen, Wei Zheng, Demetrius Albanes, Laufey Amundadottir, Sheila A Bingham, Paolo Boffetta, Marie-Christine Boutron-Ruault, Stephen J Chanock, Sandra Clipp, Robert N Hoover, Kevin Jacobs, Karen C Johnson, Charles Kooperberg, Juhua Luo, Catherine Messina, Domenico Palli, Alpa V Patel, Elio Riboli, Xiao-Ou Shu, Laudina Rodriguez Suarez, Gilles Thomas, Anne Tjønneland, Geoffrey S Tobias, Elissa Tong, Dimitrios Trichopoulos, Jarmo Virtamo, Weimin Ye, Kai Yu, Anne Zeleniuch-Jacquette, H Bas Bueno-de-Mesquita, Rachael Z Stolzenberg-Solomon.   

Abstract

Smoking is an established risk factor for pancreatic cancer; however, detailed examination of the association of smoking intensity, smoking duration, and cumulative smoking dose with pancreatic cancer is limited. The authors analyzed pooled data from the international Pancreatic Cancer Cohort Consortium nested case-control study (1,481 cases, 1,539 controls). Odds ratios and 95% confidence intervals were calculated by using unconditional logistic regression. Smoking intensity effects were examined with an excess odds ratio model that was linear in pack-years and exponential in cigarettes smoked per day and its square. When compared with never smokers, current smokers had a significantly elevated risk (odds ratio (OR) = 1.77, 95% confidence interval (CI): 1.38, 2.26). Risk increased significantly with greater intensity (> or =30 cigarettes/day: OR = 1.75, 95% CI: 1.27, 2.42), duration (> or =50 years: OR = 2.13, 95% CI: 1.25, 3.62), and cumulative smoking dose (> or =40 pack-years: OR = 1.78, 95% CI: 1.35, 2.34). Risk more than 15 years after smoking cessation was similar to that for never smokers. Estimates of excess odds ratio per pack-year declined with increasing intensity, suggesting greater risk for total exposure delivered at lower intensity for longer duration than for higher intensity for shorter duration. This finding and the decline in risk after smoking cessation suggest that smoking has a late-stage effect on pancreatic carcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19561064      PMCID: PMC2733861          DOI: 10.1093/aje/kwp134

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  25 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer.

Authors:  Han-Yao Huang; Anthony J Alberg; Edward P Norkus; Sandra C Hoffman; George W Comstock; Kathy J Helzlsouer
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

3.  Estimating the population attributable risk for multiple risk factors using case-control data.

Authors:  P Bruzzi; S B Green; D P Byar; L A Brinton; C Schairer
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

4.  Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.

Authors:  R Z Stolzenberg-Solomon; D Albanes; F J Nieto; T J Hartman; J A Tangrea; M Rautalahti; J Sehlub; J Virtamo; P R Taylor
Journal:  J Natl Cancer Inst       Date:  1999-03-17       Impact factor: 13.506

5.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

6.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

7.  Smoking and pancreatic cancer in men and women.

Authors:  J E Muscat; S D Stellman; D Hoffmann; E L Wynder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-01       Impact factor: 4.254

8.  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

Authors: 
Journal:  Ann Epidemiol       Date:  1994-01       Impact factor: 3.797

9.  Cigarette smoking and pancreas cancer: a case-control study based on direct interviews.

Authors:  D T Silverman; J A Dunn; R N Hoover; M Schiffman; K D Lillemoe; J B Schoenberg; L M Brown; R S Greenberg; R B Hayes; G M Swanson
Journal:  J Natl Cancer Inst       Date:  1994-10-19       Impact factor: 13.506

10.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

View more
  114 in total

1.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk.

Authors:  Ji-Hyun Jang; Michelle Cotterchio; Ayelet Borgida; Steven Gallinger; Sean P Cleary
Journal:  Carcinogenesis       Date:  2012-02-02       Impact factor: 4.944

3.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

4.  The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research.

Authors:  Amy E Kennedy; Muin J Khoury; John P A Ioannidis; Michelle Brotzman; Amy Miller; Crystal Lane; Gabriel Y Lai; Scott D Rogers; Chinonye Harvey; Joanne W Elena; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-20       Impact factor: 4.254

5.  Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population.

Authors:  Brian M Wolpin; Peter Kraft; Jihye Kim; Chen Yuan; Ana Babic; Ying Bao; Clary B Clish; Michael N Pollak; Laufey T Amundadottir; Alison P Klein; Rachael Z Stolzenberg-Solomon; Pari V Pandharipande; Lauren K Brais; Marisa W Welch; Kimmie Ng; Edward L Giovannucci; Howard D Sesso; JoAnn E Manson; Meir J Stampfer; Charles S Fuchs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-22       Impact factor: 4.254

6.  Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study.

Authors:  Brian Z Huang; Loic Le Marchand; Christopher A Haiman; Kristine R Monroe; Lynne R Wilkens; Zuo-Feng Zhang; Veronica Wendy Setiawan
Journal:  Int J Cancer       Date:  2018-01-12       Impact factor: 7.396

Review 7.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

8.  Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome.

Authors:  Elizabeth Won; Kenneth H Yu; Ali Shamseddine; Leonard Saltz; Deborah Mukherjee; Ali Haydar; Ashwaq El-Olayan; Sally Temraz; Mohamed Naghy; Dorothy Makanjoula; Eileen M O'Reilly; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-03

9.  Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Authors:  Christopher Y Kang; Jonathan Wang; Dierdre Axell-House; Pranay Soni; Mon-Li Chu; Galina Chipitsyna; Konrad Sarosiek; Jocelyn Sendecki; Terry Hyslop; Mazhar Al-Zoubi; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

10.  Association between allergies and risk of pancreatic cancer.

Authors:  Michelle Cotterchio; Elizabeth Lowcock; Thomas J Hudson; Celia Greenwood; Steven Gallinger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.